MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 18, 2005; DOI: 10.1124/mol.105.011601


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.011601v1
68/2/347    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, Y.-H.
Right arrow Articles by Zeng, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, Y.-H.
Right arrow Articles by Zeng, R.


Received for publication February 3, 2005.
Revised May 13, 2005.
Accepted for publication May 17, 2005.

Single Mutations at Asn295 and Leu305 in the Cytoplasmic Half of TM7 of the AT1 Receptor Induce Promiscuous Agonist Specificity for Angiotensin II Fragments - A PSEUDO-CONSTITUTIVE ACTIVITY

Ying-Hong Feng 1*, Lingyin Zhou 2, Rongde Qiu 3, Robin Zeng 4

1 Uniformed Services University of the Health Sciences 2 Case Western Reserve University 3 Uniformed Services University of the Health sciences 4 Case western Reserve University

* Address correspondence to: E-mail: yhfeng{at}usuhs.mil

Abstract

The most striking feature of a G protein-coupled receptor (GPCR) is its highly exclusive agonist specificity. This feature guarantees that a GPCR recognizes only its specific native agonist(s). Herein we show that two point mutations of N295S and L305Q enabled the AT1 receptors to recognize multiple Ang II fragments. Similar to the well-established constitutively active AT1 mutant receptor N111G, the mutations of N295S and L305Q induced an increased production of basal IP in the absence of exogenous Ang II when expressed in HEK293 cells. Distinct from the N111G, however, is the fact that the increased basal activity disappeared in COS-7 cells due to lack of endogenous Ang II fragments produced by the cells - a pseudo-constitutive activity. Surprisingly, the Ang II analog, [Sar1,Ile4,Ile8]Ang II, and the native angiotensin II fragments Ang 1-7, Ang IV, and Ang 5-8 that are inactive in activating the wild-type receptor activated N295S and L305Q. Results generated by lowering the Na+ concentration suggest that the mutant N295S and L305Q may be trapped in neutral conformational states (RN). These data have identified for the first time a novel pattern of GPCR mutations with a broad spectrum of agonist specificity, suggesting possible existence of functional GPCRs in nature that are activated through conformational "selection" rather than "induction" mechanisms.


Key words: Angiotensin, IP3/DAG, Structure-activity relationships and modeling, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches, Structure/function/mechanism


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva
The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
Physiol Rev, April 1, 2007; 87(2): 565 - 592.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics